Effects Obtained at Manual Function After Applying Anodic Transcranial Direct Current Stimulation (tCDS) in Children With Spastic Hemiparetic Cerebral Palsy
Launched by UNIVERSITY OF MALAGA · May 31, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special type of brain stimulation, called anodic transcranial direct current stimulation (tDCS), can help improve hand function in children with spastic hemiparetic cerebral palsy. Spastic hemiparetic cerebral palsy affects one side of the body, making it difficult for children to use their hands effectively. The researchers will apply the stimulation to a specific part of the brain that controls movement in the affected arm to see if it can enhance manual skills.
To be eligible for this study, children must be between 14 and 18 years old and have a diagnosis of spastic hemiparetic cerebral palsy. They should also be able to understand instructions and be stable in their health. However, children with certain medical devices, like pacemakers or defibrillators, or those who are receiving other treatments that might affect the study results, cannot participate. If enrolled, participants can expect to receive the brain stimulation in a safe environment, and their progress will be closely monitored to assess any improvements in their hand function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children between 14-18 years old.
- • Children with spastic hemiparetic cerebral palsy diagnosis.
- • Children with a cognitive level high enough to understand and to do the activities to value them.
- • Children hemodynamically stable.
- • Children forming part of levels II-IV of the Manual Ability Classification System (MACS).
- Exclusion Criteria:
- • Children with defibrillator.
- • Children with pacemaker.
- • Children with cerebral stimulator.
- • Children with intracranial metallic implants.
- • Children with opened cranial after clambering.
- • Children that receive another treatment (pharmacological or physiotherapical) that could interfere or disrupt the results.
- • Another circumstance where the electrotherapy treatment is contraindicated.
About University Of Malaga
The University of Malaga, a leading academic institution in Spain, is committed to advancing medical research and improving patient outcomes through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise in various fields, including medicine, health sciences, and biotechnology, to conduct rigorous studies. The institution is dedicated to fostering a culture of ethical research practices and ensuring the highest standards of safety and efficacy in its clinical trials, ultimately contributing to the development of groundbreaking therapies and enhancing the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Málaga, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported